Condition

Colon Neoplasm

ClinicalTrials.gov condition label

Clinical trials4

Recruiting2

Common interventions8

Lead sponsors shown4

Clinical trials

4 shown

Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer PatientsNCT07427537 · 2026-01-29

Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer CareNCT06630962 · 2024-07-15

Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory FunctionNCT04799080 · 2021-03-06

A Study of MLN8054 in Patients With Advanced Solid TumorsNCT00249301 · 2005-10-01

Common interventions

Assessment of blood concentrations of microRNAsDIAGNOSTIC_TEST1 Assessment of blood concentrations of neurofilament light chainDIAGNOSTIC_TEST1 Chemotherapy-induced peripheral neuropathy (CIPN) - gradeOTHER1 Chemotherapy-induced peripheral neuropathy (CIPN) - severityOTHER1 Financial Navigation ProgramOTHER1 MLN8054DRUG1 Neuropathic pain assessmentOTHER1 Pain assessementOTHER1

Leading sponsors

Izmir Bakircay University1 Millennium Pharmaceuticals, Inc.1 Northwestern University1 University Hospital, Clermont-Ferrand1

Trial status mix

RECRUITING2

COMPLETED1

TERMINATED1

Phase mix

NA2

PHASE11

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.